Background
==========

The evolutionary trajectory of duplicated genes has been an active area of investigation since gene duplication was first recognized as an important force in species evolution \[[@B1]\]. The availability of new sequence data and analyses has challenged the hypothesis suggesting most duplicated genes are destined to lose their function and become pseudogenes, with a few exceptions establishing new biological roles (reviewed in \[[@B2]\]). It is believed that the occurrence of gene duplication would result in relaxed selection of redundant copies permitting genes to evolve specialized sub-functions \[[@B3],[@B4]\]. Moreover, nearly identical genomic regions provide important substrates for chromosomal rearrangements that permit rapid evolutionary changes to occur in a short period of time \[[@B5]\].

An estimated 3.5-5% of the human genome has undergone recent duplication \[[@B6]-[@B9]\], and these segmental duplications (also termed duplicons or low-copy repeats) are found to be hot spots, or predisposition sites, for the occurrence of nonallelic homologous recombination. This recombination can lead to genomic mutations such as deletion, duplication, inversion, or translocation, resulting in human disease \[[@B10]\]. Many mouse strains with chromosomal aberrations are known \[[@B11]\], and it remains to be seen whether segmental duplications have a role in any of these genomic mutations.

A high-quality draft genome sequence not only makes it possible to expand the known set of duplicate genes, but also reveals their genomic context. This genomic context contains the regulatory and structural elements responsible for gene expression that need to be interrogated for a better understanding of the mechanisms and consequences of gene duplication. Furthermore, an accurate and well-annotated mouse genome is an essential resource for many in the biomedical research community, especially those who use the sequence to design and interpret transgenic, mutagenesis, microarray, and proteomic studies.

Several lines of evidence show that the whole-genome shotgun (WGS) approach yielded a high-quality draft sequence that covers roughly 96% of the euchromatic genome excluding chromosome Y (a female C57BL/6J mouse was used in the sequencing project) \[[@B12]\]. The WGS sequence reads were assembled into sequence contigs using sequence-assembly programs to produce the February 2002 MGSCv3 working draft \[[@B12],[@B13]\]. The newly released February 2003 assembly was a hybrid assembly comprising 705 megabases (Mb) of finished bacterial artificial chromosome (BAC) sequences incorporated into the MGSCv3 assembly.

We previously analyzed several versions of the human genome draft assemblies (NCBI Builds 28, 29, and 30) \[[@B9]\], and found substantial potential genome assembly errors in all builds, including approximately 40 Mb of sequence in Build 30. These assembly errors probably arose from difficulties in merging finished sequence or from incorrectly assigning sequence contigs into the genome assembly. In such cases, completely identical or nearly identical sequences (due to allelic differences or sequencing errors) would be present at distinct regions in the genome sequence. These sequence misassignment errors would yield near-perfect duplication artifacts, detected as having extremely high sequence identities (exceeding 99.5% and over 5 kilobase (kb) in length), in genome assemblies. However, a small subset of such results could represent duplications that arose from very recent evolutionary events and will require further experimental analysis.

A number of web-based resources, specifically those provided by the National Center for Biotechnology Information (NCBI), Ensembl (at the European Bioinformatics Institute and Sanger Centre), and the University of California Santa Cruz (UCSC), make the genome sequence and associated annotations readily accessible. Because of the success of the mouse genome sequencing consortium (MSGC), investigators worldwide are utilizing the draft \'as is\' in both medical and evolutionary studies. In this paper we show that even though the genome assembly is still in draft form, an initial analysis of the sequence can reveal novel genomic duplications and demarcate regions of the genome that require additional examination.

Results and discussion
======================

We performed a search for all recent segmental duplications that were larger than 5 kb in size and showed greater than 90% sequence identity from both the February 2002 (numerical results for February 2002 assembly are presented at our web site \[[@B14]\]) and the February 2003 mouse genome sequence assemblies \[[@B15]\]. Our method was based on pairwise (mega-) BLAST2 \[[@B16]\] sequence comparisons between entire chromosome sequences. From our analysis of the February 2003 assembly, a total of 33.6 Mb (1.2%) of the genome sequence (2,695 Mb) was found to be involved in recent segmental duplications (Table [1](#T1){ref-type="table"}) and 8.9 Mb of this sequence was unmapped data (found in the unmapped chromosome sequence). On the basis of the 20 mapped chromosomes, more than 712 distinct intrachromosomal segmental duplications, comprising 19.9 Mb of sequence (Figure [1](#F1){ref-type="fig"}), and 475 distinct interchromosomal duplications, comprising 7.1 Mb of sequence, were identified. We also found that 57% of the duplications were in tandem, which we defined as two related intrachromosomal duplicons located within 200 kb of one another.

Duplications can be found in all chromosomes analyzed, with chromosomes 6, 7, 17, and X having the highest, and chromosome 18 having the least, duplicated content (Table [1](#T1){ref-type="table"}, Figure [1](#F1){ref-type="fig"}). Substantial amounts (8.9 Mb) of the duplicated content are found in the unmapped chromosome (ChrUn) sequence, suggesting that the correct chromosomal assignment of these segments remains a major assembly challenge. It is possible that small subsets of these duplications are due to chimeric reads and other sequencing artifacts and thus should not be part of the finished genome sequence. On the other hand, these unmapped duplicated sequences represent true duplications that have been excluded from the assembly. One example of this occurs with a member of the mouse Bcl2 family of apoptosis regulators, Bcl2a1. Bcl2a1 contains four highly similar genes (\> 97% identical at the nucleotide level) that have been mapped together on chromosome 9 of the C57BL/6 and 129SV genomes \[[@B17],[@B18]\]. Currently, the Bcl2a1 genes are not assembled on the mapped chromosome and are found in three distinct unmapped contigs. In the human genome only one copy of *BCL2A1*is found, although a recent, independent 8.5 kb tandem duplication containing the last exon of *BCL2A1*has occurred, forming a novel *BCL2A1*-related transcript (AF249277). An example of a region that has changed between assemblies is the *Amy2*locus. *Amy2*is known to vary in copy number between inbred strains of mice \[[@B19]\]. In the February 2002 assembly, only one copy of the *Amy2*gene resided on chromosome 3 in addition to a second copy found on a large 10 kb unmapped contig. In addition, partial high identity matches (\> 95%) to four distinct unmapped contigs were found (note that these partial copies were not detected in our analysis as they are less than 5 kb long). In the February 2003 assembly, six *Amy2*genes exist, which is close to the five *Amy2*-like genes that were detected in the genome of strain A/J mice using quantitative densitometry of Southern blots \[[@B20]\]. It is, however, important to note that a gap, not bridged by a clone, still exists between the *Amy2*locus and the *Amy1*gene, and so the copy number in the C57BL/6J genome assembly may still vary.

We analyzed the distribution of segmental duplication content by sorting the duplications into six different sequence-similarity categories: 90-92%, 92-94%, 94-96%, 96-98%, 98-99.5%, and 99.5-100%, for both the February 2002 and 2003 assembly builds (Table [2](#T2){ref-type="table"}). The amount of duplication content appears to be unevenly distributed across these categories, with a distinct rise in the 94-96% category. This might suggest recent duplicative events in the mouse genome have not occurred at a steady rate. However, it is unclear at this point how these results were affected by the draft status of the genome assemblies. Between the 2002 and the 2003 assembly builds we found that the amount of duplication content is nearly the same within each percent category except for the 99.5-100% category, which contained 4.8 Mb of sequence in 2002 and 18.5 Mb in 2003 (Table [2](#T2){ref-type="table"}). Furthermore, we determined that the majority (88%) of the duplicated sequence in the 99.5-100% category occurred intrachromosomally, within 200 kb of each other. Using the assembly component tables (provided by UCSC \[[@B21]\]), which contain information about the underlying makeup of the February 2003 genome assembly (shotgun-assembled scaffolds and BAC sequences), we found that 215/216 (99.5%) of these duplications involved a BAC sequence. Hence, we suspect that the large increase in near-identical duplications could be the result of sequence misassignment errors arising from the inherent difficulty of merging finished BAC sequence with shotgun sequence contigs.

We previously observed that the human genome sequence assembled by Celera\'s WGS method \[[@B22]\] showed poor quality in regions with near-identical segmental duplications \[[@B23]\]. To assess the finishing status of duplicated regions in the WGS mouse genome assembly (February 2002 MGSCv3 assembly), we calculated the amount of unfinished sequence (regions with gaps or Ns) within the immediate neighborhood (20 kb) of each duplicon (the unmapped chromosome sequence was excluded from this analysis). We observed substantially higher amounts of unfinished sequence (number of Ns) in these regions. Whereas 8.0% of the assembly is comprised of Ns, regions harboring duplications contain an average of 12.2%. This average rises to 16.6% for duplications with more than 98% sequence identity (statistics can be obtained from our website \[[@B14]\]). This suggests that the WGS assembler had difficulty assembling regions containing recent sequence duplication and that these regions are good candidates for finishing using clone resources.

Using the NCBI Refseq and Ensembl mouse gene annotation, we identified 675 genes that mapped to duplicated regions of the mouse genome (a full list of genes can be obtained from our website \[[@B14]\]); 414 of these genes were found to be fully contained within a segmental duplication, thus representing the best candidates for whole-gene duplication. While it is likely that some of these duplicate copies have become pseudogenes, others may have evolved specialized functions \[[@B3]\]. Moreover, we sought to use the identified gene sequences, which were expressed sequence tags (ESTs) and/or cDNAs, as experimentally derived resources to help validate the genomic duplication content presented in this study. We aligned duplicated gene sequences to each genomic region using UCSC BLAT \[[@B17]\] and determined their percent identity matches. Unambiguous gene-to-genomic identity matches were established for all 128 gene pairs we examined. Each gene sequence was mapped to their respective genomic region with at least 99.1% identity (examples are shown in Table [3](#T3){ref-type="table"}; a full table is available at \[[@B14]\]). We also examined the identified duplicated genes using their InterPro protein-domain classification present in 608 Ensembl genes to see whether specific kinds of genes or protein domains have been preferentially duplicated. We found that genes containing protein domains related to signal transduction (rhodopsin-like G-protein-coupled receptor superfamily), olfaction (olfactory receptors, vomeronasal receptors) immunity (immunoglobulin/MHC, serine protease), and drug metabolism (cytochrome P450) are significantly enriched (by at least threefold) (Table [4](#T4){ref-type="table"}).

From this list of genes, we performed a detailed analysis of *Mater*, a maternal-effect gene of potential medical importance. *Mater*encodes an autoantigen in a mouse model for human autoimmune premature ovarian failure \[[@B24]\]. Knockout studies have shown that it is essential for early embryonic development in mice \[[@B25]\]. *Mater*encodes a protein of 1,111 amino acids from a 3.5 kb transcript that spans 57 kb on mouse chromosome 7. A 42 kb segmental duplication involving two duplicons (DUP1, where *Mater*is located; DUP2, where a novel *Mater2*is located) are situated about 5 Mb apart and in an inverted orientation (Figure [2](#F2){ref-type="fig"}). DUP1 and DUP2 are on average 91.1% identical over the entire 42 kb genomic region, with a 96.6% average in the exonic regions. Furthermore, we identified an intron-less *Mater*pseudogene (*MaterP*), which shares 87% DNA sequence identity to *Mater*, at a location 10 Mb proximal to *Mater*(Figure [2](#F2){ref-type="fig"}; see Additional data files for a detailed comparative genomic analysis of the *Mater*locus). The mapping locations of these duplications have been confirmed by fluorescence *in situ*hybridization (FISH) (Figure [3](#F3){ref-type="fig"}). Thus, *Mater*serves as one example of a gene that has been knocked out in mice but for which there is a second, highly similar transcript whose biological role is not yet known.

In addition, we were interested in determining whether any of the 675 genes have undergone recent (≥ 90% sequence identity over ≥ 5 kb) and independent duplication in the human genome. Some of these genes could be recently evolving via the \'birth and death model of evolution\' which has been used to describe the evolution of the major histocompatibility complex (MHC) and immunoglobulin multigene families \[[@B26]\]. This model describes genes that are repeatedly created through duplication, with some genes becoming fixed while others are rendered nonfunctional by deleterious mutations \[[@B26]\].

We examined the 675 duplicated mouse genes using best reciprocal BLAST hits to identify their putative human orthologs. We subsequently analyzed regions containing these putative orthologs for recent sequence duplication in the human genome. Sixteen of the 675 genes were found to be involved in recent, independent gene duplication in mouse and human (see Table [5](#T5){ref-type="table"}). Some of these regions containing whole-gene duplications are part of multigene families known to be evolving via duplication and are found in tandem duplicated arrays in both species (that is, the *Amy2*, *H2-Q1*, *Gsta1*, and *Olfr54*genes). An interesting example of a recent and apparently independent whole-gene duplication that occurred in mouse and human involves *Bmp8a*and a second intronic transcript *Oxct2*. Of the partial gene duplications, the recent duplication within the *Tnxb*gene and its human ortholog *TNXB*(found at the MHC III locus of mouse chromosome 17 and human 6p21) is particularly intriguing. In humans, this locus consists of a tandem array of genes (*RP*, *C4*, *CYP21*, and *TNXB*(RCCX)), which through gene duplication, can exist as mono-, di- and tri-modular forms in the caucasian population \[[@B27]\]. Recent studies have also shown the presence of a deletion haplotype in one individual, leading to a fusion of the *TNXA*/*TNXB*gene on one chromosome and a duplication of *CYP21*on the other chromosome \[[@B28]\]. Furthermore, complex haplotypes of the complement genes (*C4A*and *C4B*) residing in the RCCX module have been characterized and postulated to have a role in individual susceptibility to infection and autoimmune disease \[[@B29]\]. A closer inspection of the genomic region surrounding this recent duplication in the mouse reveals that the C57BL/6J duplication encompasses homologous genes (*Tnxb*, *Slp*(a *C4*paralog), *Cyp21a1*, and *C4*). Similarly, in humans, this orthologous region of the mouse genome has been shown to undergo multiple recombination events, giving rise to a variety of haplotypes \[[@B30]\]. Overall, many of the genes that have recently experienced duplications in the mouse and human genomes are of biomedical and evolutionary interest. The complexity and polymorphic nature of these recent duplications underscores the need for, and the difficulty of, performing the detailed structural and functional analyses that will help discern their true genomic organization, evolutionary history, and biological implications.

Conclusions
===========

Our current analysis of the presence and organization of recent segmental duplications in the mouse genome has identified recent gene-duplication events and potentially problematic regions of the mouse genome assembly. At a practical level, identifying regions with segmental duplication will be useful in highlighting the most dynamic regions of any mammalian genome assembly. For the genome-sequencing community, these potential misassemblies/putative duplications can become initial targets for clone-based finishing; and for the biologist, they can serve as sentinels for regions of the genome most likely to change in subsequent assemblies. Additional hierarchical shotgun sequencing effort \[[@B12]\] will undoubtedly be critical to finish the mouse genome sequence and reveal additional duplicated regions that are incomplete at the moment.

Many of the duplicated genes are of evolutionary and medical importance (that is, genes involved in immune defense, olfaction, and drug metabolism). Knowledge of these duplicated regions could be important for accurately mapping mutants derived from ethylnitrosourea (ENU) mutagenesis, designing targeting vectors for embryonic stem cell alterations, and validating putative single-nucleotide polymrophisms (SNPs) that may have arisen from recently duplicated sequences rather than allelic variants \[[@B31]\]. The ability to create large, sophisticated targeting vectors, by engineering BACs using homologous recombination in *Escherichia coli*\[[@B32]\], should prove very useful for designing *in vivo*experiments aimed at dissecting the function of recently duplicated genes. Knowledge of all recent duplications in mouse may also highlight regions subject to chromosomal rearrangement and polymorphism within and between species, and provide an opportunity to model the stability of such genomic architecture in a mammalian genome.

Materials and methods
=====================

Genome sequence and chromosome-wide BLAST
-----------------------------------------

We obtained the February 2002 (MGSCv3) and February 2003 mouse genome assemblies (lower-case repeat-masked sequences), as well as the assembly component tables, through the UCSC Human Genome Browser website \[[@B21]\]. For each assembly, detection of intrachromosomal segmental duplications involved comparing each of the 20 masked chromosome sequences (excluding the Y chromosome not targeted by the MGSC) and the masked unmapped chromosome sequence against itself by BLAST2 \[[@B16]\] (21 comparisons made). Interchromosomal analysis of segmental duplications involved pairwise comparisons between each of the 21 chromosomes (420 comparisons made). Analyses were repeated with the exclusion of the unmapped chromosome sequence to examine its contribution to the overall duplication content (results posted at \[[@B14]\]). All BLAST results were subsequently parsed to eliminate low-quality and fragmented alignments under the following criteria: BLAST results having ≥ 90% sequence identity, ≥ a length of 80 bp, and with expected value ≤ 10^-30^.

Parsing of BLAST results and duplication detection
--------------------------------------------------

Each BLAST report was sorted by chromosomal coordinates. All identical hits (same coordinate alignments), including suboptimal BLAST alignments recognized by multiple, overlapping alignments, as well as mirror hits (reverse coordinate alignments) from the BLAST results of the intrachromosomal set, were removed. Contiguous alignments separated by a distance of less than 3 kb, then 5 kb, and subsequently 9 kb, were joined stepwise into modules in order to traverse masked repetitive sequences and to overcome breaks in the BLAST alignments caused by insertions/deletions and sequence gaps. Such contiguous sequence-alignment modules represent sequence similarity between the subject and query chromosome sequence in question (at their respective positional coordinates) \[[@B9]\]. Potential sequence misassignment errors are results detected to have \> 99.5% sequence identity with another region.

Online database for recent segmental duplications
-------------------------------------------------

We overlaid all duplication content and regions containing potential sequence misassignment errors onto the mouse genome sequence, which can be viewed using the interactive Generic Genome Browser \[[@B33]\] hosted at our website \[[@B14]\]. Results and analyses were presented for both the February 2002 and February 2003, each as a separate database. Results are also summarized in tables that include information on chromosomal coordinates, band locations, size of duplications, level of identity between duplicated copies, as well as genes mapped to these regions \[[@B14]\]. Graphical representation for intrachromosomal duplications was generated using the visualization tool GenomePixelizer (Figure [1](#F1){ref-type="fig"}) \[[@B34]\].

Identification of recent gene duplications
------------------------------------------

We obtained the NCBI Refseq gene annotation file (refGene.txt.gz) from the UCSC Downloads website \[[@B21]\] and the Ensembl gene annotation (Mus_musculus.cdna.fa.gz; Ensembl Known genes only) from the Ensembl website \[[@B35]\]. Genes that mapped to duplicated regions of the mouse genome were identified using their chromosome sequence coordinates. In total, 439 Refseq and 608 Ensembl annotated genes were found to be involved in duplicated regions; together these two datasets made up 675 unique gene annotations (372 overlapped annotations). To establish gene-pair relationships between duplicated gene sequences, each of the 238 NCBI RefSeq genes that were found to be fully contained within a segmental duplication was searched against the UCSC and NCBI GenBank database for spliced ESTs, full-length cDNAs and additional annotated genes. A total of 128 gene pairs were established, most of which are likely to be novel gene paralogs previously unknown in the literature. In the analysis of protein-domain enrichment in duplicated genes, InterPro annotation for duplicated genes (608 Ensembl genes) as well as for the entire gene set (16,515) was obtained from Ensembl EnsMart \[[@B36]\]. We counted the number of times a protein-domain class is found in each gene set and tabulated our results (see Table [4](#T4){ref-type="table"}). To examine the subset of genes that had undergone recent duplication in the human genome, each of the duplicated gene sequences was aligned to the June 2002 human genome assembly by BLAST (with an initial expected value cutoff of \<10^-10^). The best-aligned human genes were subsequently used for reciprocal BLAST alignments (against the mouse genome sequence) to establish a putative orthologous relationship between the mouse and human gene pairs. Using results from our human genome duplication analysis \[[@B37]\], we examined regions of the human genome where the human genes were involved in recent segmental duplication.

Fluorescence *in situ* hybridization (FISH)
-------------------------------------------

Mouse lymphocytes were isolated from the spleen and cultured at 37°C in RPMI 1640 medium supplemented with fetal calf serum, concanavalin A and lipopolysaccharide. After 44 hours, the cultured lymphocytes were treated with bromodeoxyuridine for an additional 14 hours. The synchronized cells were washed and recultured at 37°C for 4 hours in a-minimal Eagle\'s medium with thymidine. Chromosome slides were made by conventional methods including hypotonic treatment, fixation and air-drying \[[@B38]\]. BAC probes RP23-225F5 (mapped to the *Mater*locus (DUP1) by BAC-end sequences) and RP23-464L20 (a control probe) were biotinylated respectively. Hybridization and detection were carried out according to \[[@B39]\]. FISH signals were observed under fluorescent microscopy using FITC and DAPI filters. Images were captured by CCD camera.

Additional data files
=====================

Further analysis of Mater duplication, including a figure showing a multiple percent identity plot of *Mater*versus *Mater2*, *MATER*(human), and *MaterP*, is available (additional data file [1](#s1){ref-type="supplementary-material"}).

Supplementary Material
======================

###### Additional data file 1

Further analysis of Mater duplication

###### 

Click here for additional data file
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Figures and Tables
==================

![Intrachromosomal segmental duplications identified in the mouse genome (chromosomes 1-X; results are based on the February 2003 assembly). Each line represents a duplicated module and connects a paralogous duplicon pair. Red, 99-100% sequence identity; purple, 96-98%; green, 93-95%; and blue, 90-92%. Correspondences to chromosome ideograms (obtained from Ensembl) are only crude. Graphics were produced using GenomePixelizer \[[@B34]\].](gb-2003-4-8-r47-1){#F1}

![The genomic organization of the *Mater*duplication. **(a)**Location of the *Mater*duplication. A snapshot view of GMOD browser (details can be found at \[[@B14]\]). **(b)**Chromosomal view (mouse chromosome 7) of the three *Mater*duplication locations (DUP1, DUP2, *MaterP*). **(c)**Graphical view of the sequence similarity between DUP1 and DUP2 shown by GenomePixelizer. DUP2 is situated in an inverse orientation with respect to DUP1. Red, 99-100% sequence identity; purple, 96-98%; green, 93-95%; blue, 90-92%; black, 85-89%. **(d)**Graphical view of the sequence similarity between DUP1 and the *MaterP*region. As shown, *MaterP*is an intron-less, retrotransposed pseudogene. Blue, 90-92% sequence identity; black, 85-89%.](gb-2003-4-8-r47-2){#F2}

![FISH detection of *Mater*duplication. **(a)**Metaphase FISH showing three pairs of signals (yellow) detected on mouse chromosome 7 using BAC clone RP23-225F5 (detection frequency of 70%) mapping to duplicated *Mater*regions. **(b)**DAPI banding of the same partial mitotic figures for the identification of mouse chromosome 7. A control probe RP23-464L20 was mapped to a single location in the F2 region (data not shown).](gb-2003-4-8-r47-3){#F3}

###### 

Recent segmental duplication in the mouse genome

  Chromosome   Chromosome length   Intrachromosomal duplication   \%    Interchromosomal duplication   \%    Total        \%
  ------------ ------------------- ------------------------------ ----- ------------------------------ ----- ------------ -----
  1            195,869,683         1,392,568                      0.7   238,739                        0.1   1,552,908    0.8
  2            181,423,755         1,106,879                      0.6   173,602                        0.1   1,184,304    0.7
  3            160,674,399         790,500                        0.5   158,011                        0.1   948,511      0.6
  4            152,921,959         1,743,027                      1.1   647,795                        0.4   1,921,970    1.3
  5            149,719,773         1,102,772                      0.7   761,950                        0.5   1,560,683    1.0
  6            149,950,539         2,042,585                      1.4   562,415                        0.4   2,339,839    1.6
  7            134,401,573         1,655,438                      1.2   713,287                        0.5   2,038,845    1.5
  8            128,923,138         738,203                        0.6   331,970                        0.3   1,005,575    0.8
  9            124,467,299         437,352                        0.4   188,427                        0.2   623,089      0.5
  10           130,738,012         345,768                        0.3   258,429                        0.2   604,197      0.5
  11           122,862,689         900,355                        0.7   127,774                        0.1   1,012,479    0.8
  12           114,462,600         1,139,786                      1.0   374,365                        0.3   1,404,279    1.2
  13           116,242,670         855,835                        0.7   547,462                        0.5   1,349,974    1.2
  14           115,844,145         450,161                        0.4   451,782                        0.4   748,465      0.6
  15           104,111,694         443,805                        0.4   43,937                         0.0   487,742      0.5
  16           98,986,639          389,255                        0.4   67,290                         0.1   456,545      0.5
  17           93,529,596          1,329,664                      1.4   660,440                        0.7   1,760,982    1.9
  18           91,041,441          162,916                        0.2   58,996                         0.1   210,422      0.2
  19           61,093,376          328,909                        0.5   193,387                        0.3   479,687      0.8
  X            149,996,094         2,592,361                      1.7   574,950                        0.4   3,018,682    2.0
  chrUn\*      117,911,829         6,049,538                      5.1   5,710,057                      4.8   8,885,604    7.5
                                                                                                                          
  Total        2,695,172,903       25,997,677                     1.0   12,845,065                     0.5   33,594,782   1.2

The analysis is based on the February 2003 mouse genome assembly. \*chrUn, unmapped chromosome sequence.

###### 

Comparison between genome assemblies

  Sequence identity level                                   February 2002 assembly\*   February 2003 assembly
  --------------------------------------------------------- -------------------------- ------------------------
  Duplication content (bp)                                                             
  90-92%                                                    4,966,470                  3,543,429
  92-94%                                                    15,685,840                 13,981,642
  94-96%                                                    17,533,730                 17,970,287
  96-98%                                                    11,539,392                 11,731,958
  98-99.5%                                                  5,865,024                  5,487,899
                                                                                       
  ^†^Potential sequence misassignment error detected (bp)                              
  99.5-100%                                                 4,832,594                  18,456,096

The comparison is of duplication content by sequence identity and potential sequence misassignment errors between the February 2002 (MGSCv3) and February 2003 (a hybrid assembly of MGSCv3 with 705 Mb finished BAC sequence) genome assemblies. \*Analysis of the duplication content for February 2002 assembly can be found at \[[@B14]\].^†^Sequences detected to show extremely high percent identity duplications are likely to be genome assembly artifacts and were not included in the duplication content shown in Table [1](#T1){ref-type="table"}.

###### 

Examples of recent mouse gene duplications

  Locus1\*   Gene        Percent identity^†^   Annotation                                     Locus2\*   Gene        Percent identity^†^   Annotation                                     Duplication % identity^‡^
  ---------- ----------- --------------------- ---------------------------------------------- ---------- ----------- --------------------- ---------------------------------------------- ---------------------------
  1 F        NM_009888   99.6                  Cfh (Complement component factor h)            1 F        M29010      99.0                  Complement factor H-related protein mRNA       97.1
  3 G1       NM_009669   100                   Amy2 (Amylase 2, pancreatic)                   3 G1       M11896      99.6                  Pancreatic amylase B-1                         97.6
  5 E2       NM_053184   99.9                  Ugt2a1 (UDP glycosyltransferase 2 A1)          5 E2       BF144793    99.6                  cDNA clone IMAGE:4021939                       95.7
  5 E2       NM_009467   100                   Ugt2b5(UDP-glucuronosyl-transferase 2b5)       5 E2       NM_053215   100                   RIKEN cDNA 0610033E06 gene                     93.3
  5 E4       NM_008620   99.9                  Mpa2 (macrophage activation 2)                 5 E4       BC007143    99.5                  Similar to macrophage activation 2             90.6
  5 G1       NM_029693   100                   RIKEN cDNA 1700123K08                          7 B2       NM_027702   100                   RIKEN cDNA 4933421I07 gene                     91.1
  6 C1       NM_053238   100                   V1rc8 (Vomeronasal 1 receptor, C8)             6 C1       NM_053239   99.7                  V1rc9 (Vomeronasal 1 receptor, C9)             95.1
  6 D1       NM_011467   99.9                  Spr (sepiapterin reductase)                    6 D1       BE862957    99.5                  EST sequence                                   95.8
  6 F1       AI505330    100                   Similar to initiation factor eIF-4AI           6 F1       AI503670    99.8                  Similar to initiation factor eIF-4AI           98.9
  6 F2       NM_008646   99.9                  Mug2 (Murinoglobulin 2)                        6 F2       NM_008645   99.9                  Mug1 (Murinoglobulin 1)                        94.6
  6 F3       NM_020257   99.8                  Dcl1 (c-type lectin 1)                         6 F3       NM_027562   99.9                  4632413B12Rik (C-lectin related protein)       90.8
  6 F3       NM_008463   99.7                  Klra5 (Killer cell lectin-like receptor, A5)   6 F3       NM_008464   99.5                  Klra6 (Killer cell lectin-like receptor, A6)   90.0
  6 F3       NM_010649   99.8                  Klra4 (Killer cell lectin-like receptor A4)    6 F3       NM_016659   99.8                  Klra1 (Killer cell lectin-like receptor A1)    91.4
  6 F3       NM_010737   99.8                  Klrb1b (Killer cell lectin-like receptor 1b)   6 F3       NM_008527   99.9                  Klrb1c (Killer cell lectin-like receptor 1c)   90.8
  7 A2       NM_011860   100                   Mater (Maternal effect gene)                   7 A1       AK016782    100                   Similar to Mater protein                       96.6
  7 B1       NM_032541   100                   Hamp hepcidin antimicrobial peptide            7 B1       AK007975    99.8                  Prohepcidin homolog                            92.8
  7 B2       NM_010115   99                    Klk13 (Kallikrein 13)                          7 B2       NM_008454   99.9                  Klk16 (Kallikrein 16)                          92.2
  8 D1       L11333      99.9                  Carboxylesterase                               8 D1       NM_144511   100                   Es31                                           95.2
  9 F4       NM_130864   99.6                  Acaa acetyl-Coenzyme A acyltransferase         9 F4       BC019882    100                   Similar to acetyl-CoA acyltransferase          96.6
  10 B3      NM_013532   99.9                  Gp49a (Glycoprotein 49A)                       10 B3      NM_008147   100                   Gp49b (glycoprotein 49B)                       96.7
  10 D2      NM_017372   100                   Lyzs (Lysozyme)                                10 D2      NM_013590   99.8                  Lzp-s (P lysozyme structural)                  95.3
  11 A3.2    NM_172792   100                   hypothetical protein 4932414J04                17 D       AK03001     100                   Tyrosine protein kinase/cysteine-rich region   94.0
  11 B1.3    NM_011396   99.9                  Slc22a5 (Solute carrier family 22)             11 B1.3    NM_019723   100                   Slc22a9 (solute carrier family 22)             91.2
  11 D       NM_021347   100                   Gsdm (Gasdermin)                               11 D       NM_029727   99.9                  2200001G21Rik                                  94.2
  12 F1      BC002065    99.6                  Serine protease inhibitor 2-1                  12 F1      BY761363    99.9                  EST sequence                                   92.2
  12 F1      NM_013772   100                   Tcl1b3 (T-cell leukemia/lymphoma 1B, 3)        12 F1      NM_013776   100                   Tcl1b5 (T-cell leukemia/lymphoma 1B, 5)        95.3
  13 A1      NM_013778   99.5                  Akr1c13 (Aldo-keto reductase 1, C13)           13 A1      NM_013777   99.5                  Akrc12 (Aldo-keto reductase 1, C12)            96.1
  13 A3      NM_008864   99.2                  Csh1 (chorionic somatomammotrophin 1)          13 A3.3    AK082929    100                   Similar to placental lactogen 1                98.8
  13 A4      NM_011456   100                   Spi14 (Serine Protease Inhibitor 14)           13 A4      NM_011455   100                   Spi13 (serine protease inhibitor 13)           95.2
  13 D1      NM_010872   100                   Birc1b (Neuronal apoptosis inhibitory 2)       13 D1      NM_008670   99.9                  Birc1a (Neuronal apoptosis inhibitory 1)       90.0
  14 C1      NM_010373   99.7                  Gzme (Granzyme E)                              14 C1      NM_010372   99.9                  Gzmd (Granzyme D)                              94.7
  14 C2      NM_172603   100                   4933417L10Rik                                  14 C3      BE381578    100                   EST sequence                                   94.0
  15 E2      NM_007781   100                   Csf2rb2 (Colony stimulating factor 2, β-2)     15 E2      NM_007780   99.8                  Csf2rb1 (Colony stimulating factor 2, β-1)     95.0
  15 E2      NM_010005   100                   Cyp2d10 (Cytochrome P450, 2d10)                15 E2      NM_010006   100                   Cyp2d9 (cytochrome P450, 2d9)                  92.1
  16 B1      NM_023125   100                   Kng (Kininogen)                                16 B1      BI330914    99.1                  EST sequence                                   90.0
  16 B3      M92418      99.8                  MS2 (Cysteine proteinase inhibitor)            16 B3      BB654253    100                   EST sequence                                   95.2
  17 B2      NM_009780   99.9                  C4 (Complement component 4)                    17 B2      M21576      99.5                  Slp (MHC sex-limited protein)                  96.3
  X A2       NM_008955   100                   Psx1 (Placenta specific homeobox 1)            X A2       NM_023894   100                   Homeobox protein GPBOX                         91.6

\*Locations of duplicons by mouse chromosome banding; locus 1 and 2 represent a duplication pair. ^†^Alignment percent identity between gene and genomic sequences showing correct matches. ^‡^% similarity: average DNA percent identity between paralogous gene/transcript sequences in locus 1 and 2 (duplicated pair)

###### 

Protein domain enrichment found in recently duplicated mouse genes\*

  InterPro entry ID   Protein domain description                          Number found in 608 duplicated genes   Number found in all 16,515 annotated genes in genome   Enrichment^†^
  ------------------- --------------------------------------------------- -------------------------------------- ------------------------------------------------------ ---------------
  IPR000276           Rhodopsin-like GPCR superfamily                     135                                    1229                                                   3.0
  IPR000725           Olfactory receptor                                  103                                    861                                                    3.3
  IPR003006           Immunoglobulin/major histocompatibility complex     46                                     372                                                    3.4
  IPR004072           Vomeronasal receptor, type 1                        31                                     108                                                    7.8
  IPR001909           KRAB box                                            23                                     103                                                    6.1
  IPR001254           Serine protease, trypsin family                     21                                     117                                                    4.9
  IPR002401           E-class P450, group I                               20                                     61                                                     8.9
  IPR001128           Cytochrome P450                                     20                                     68                                                     8.0
  IPR007086           Zn-finger, C2H2 subtype                             20                                     139                                                    3.9
  IPR001314           Chymotrypsin serine protease, family S1             19                                     108                                                    4.8
  IPR002403           E-class P450, group IV                              17                                     56                                                     8.2
  IPR002397           B-class P450                                        13                                     29                                                     11.9
  IPR001304           C-type lectin                                       13                                     96                                                     3.7
  IPR000215           Serpin                                              12                                     48                                                     6.8
  IPR002402           E-class P450, group II                              9                                      14                                                     18.5
  IPR006046           Glycoside hydrolase family 13                       7                                      8                                                      23.0
  IPR006047           Alpha amylase, catalytic domain                     7                                      10                                                     19.2
  IPR001400           Somatotropin hormone                                7                                      32                                                     6.1
  IPR006048           Alpha amylase, C-terminal all-beta domain           6                                      7                                                      24.7
  IPR002018           Carboxylesterase, type B                            6                                      13                                                     12.3
  IPR004073           Vomeronasal receptor, type 2                        6                                      13                                                     12.3
  IPR001039           Major histocompatibility complex protein, class I   6                                      17                                                     9.9
  IPR001828           Extracellular ligand-binding receptor               6                                      29                                                     5.5
  IPR002213           UDP-glucoronosyl/UDP-glucosyl transferase           5                                      12                                                     11.8
  IPR002448           Odour-binding protein                               4                                      9                                                      13.2
  IPR000068           Extracellular calcium-sensing receptor              4                                      10                                                     11.0

\*Only Ensembl gene annotation (608 genes) was used in this analysis. ^†^All results shown are statistically significant with *p*-values \< 10^-5^(chi^2^test).

###### 

Genes that have undergone recent duplication in both the mouse and human genome\*

  Refseq^†^     Gene description
  ------------- -------------------------------------------------------------------------------------
  *NM_007534*   *B-cell leukemia/lymphoma 2 related protein A1b (Bcl2a1b)*
  NM_007558     Bone morphogenetic protein 8a (Bmp8a)
  NM_007812     Cytochrome P450, 2a5 (Cyp2a5)
  *NM_008181*   *Glutathione S-transferase, alpha 1 (Ya) (Gsta1)*
  *NM_010390*   *Histocompatibility 2, Q region locus 1 (H2Q1)*
  NM_009467     UDP-glucuronosyltransferase 2 family, member 5 (Ugt2b5)
  *NM_009669*   *Amylase 2, pancreatic (Amy2)*
  NM_009888     Complement component factor h (Cfh)
  NM_010856     Myosin heavy chain, cardiac muscle, adult (Myhca)
  NM_013778     Aldo-keto reductase family 1, member C13 (Akr1c13)
  *NM_022033*   *3-Oxoacid CoA transferase 2 (Oxct2) (Imbedded in the Bmp8a gene)*
  *NM_026419*   *Elastase 3B, pancreatic (Ela3b)*
  NM_031176     Tenascin XB (Tnxb)
  NM_130864     Acetyl-coenzyme A acyltransferase (peroxisomal 3-oxoacyl-Coenzyme athiolase) (Acaa)
  *NM_010997*   *Olfactory receptor 54 (Olfr54)*
  NM_031170     Keratin complex 2, basic, gene 8 (Krt2-8)

\*Six hundred and seventy-five duplicated mouse gene sequences were aligned to the June 2002 human genome assembly by BLAST (with an initial expected value cutoff of \<10^-10^). The best aligned human genes were subsequently used for reciprocal BLAST alignments (against the mouse genome sequence) to establish a putative orthologous relationship between the mouse and human gene pairs. Using results from our human genome duplication analysis \[[@B9],[@B37]\], we examined regions of the human genome where the human genes are involved in recent segmental duplication. ^†^Italics represents genes that are entirely within a duplication in the mouse genome.
